Filing Details
- Accession Number:
- 0001225208-10-011168
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-04-28 13:00:00
- Reporting Period:
- 2010-04-26
- Filing Date:
- 2010-04-28
- Accepted Time:
- 2010-04-28 16:05:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 885725 | Boston Scientific Corp | BSX | Surgical & Medical Instruments & Apparatus (3841) | 042695240 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 901430 | E John Abele | One Boston Scientific Place Natick MA 01760-1537 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-04-26 | 25,000 | $7.13 | 4,691,949 | No | 4 | S | Indirect | By LLC |
| Common Stock | Disposition | 2010-04-26 | 50,000 | $7.14 | 4,641,949 | No | 4 | S | Indirect | By LLC |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By LLC |
| No | 4 | S | Indirect | By LLC |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 13,143,721 | Direct | |
| Common Stock | 400,000 | Indirect | By Spouse |
| Common Stock | 351,098 | Indirect | By Trust |
Footnotes
- Sales reported on this form were transacted pursuant to a 10b5-1 trading plan.
- The weighted average sales price is reported as stock sales were aggregated for reporting purposes. The per share transaction price ranged from $7.27 to $7.02. The reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
- Common stock held by a limited liability company of which reporting person holds 100% membership interest.
- The weighted average sales price is reported as stock sales were aggregated for reporting purposes. The per share transaction price ranged from $7.26 to $7.02. The reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices.
- Common stock held by the reporting person's wife. The reporting person disclaims beneficial ownership of these shares.
- Common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. The reporting person disclaims beneficial ownership of these shares.
Billionaire Hedge Funds
